We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Multiple Coagulation Parameters Predict Postoperative Bleeding Volume in Cardiovascular Surgery

By LabMedica International staff writers
Posted on 02 Dec 2021
Print article
Image: The CP3000Automated Coagulation System measures various coagulation factors (Photo courtesy of Sekisui Medical Company)
Image: The CP3000Automated Coagulation System measures various coagulation factors (Photo courtesy of Sekisui Medical Company)
Coagulopathy and massive bleeding are severe complications of cardiovascular surgery, particularly occurring after procedures requiring prolonged cardiopulmonary bypass (CPB). During surgery massive transfusion of blood products may become necessary.

Reliable and predictive laboratory tests on coagulation function will help guide clinicians to appropriate transfusion and possibly decrease variability in transfusion practices. Appropriate coagulation parameters would help to predict bleeding after cardiovascular surgery and measuring multiple coagulation parameters may prove useful.

Medical Laboratorians at the Asahikawa Medical University Hospital (Asahikawa, Japan) and their colleagues in a prospectively study collected cohort of 48 patients undergoing cardiovascular surgery from November 2015 to March 2016. They examined the association between coagulation parameters and bleeding volume. The median age of the cohort was 69 years, 29 males and 19 females and all were ethnically Asian.

The team measured prothrombin time (PT) or activated partial thromboplastin time (APTT) and fibrinogen (Fib) with the Coapresta2000 automated analyzer (coagulation one-stage assay (Sekisui Medical Company, Tokyo, Japan). Activities of coagulation factor II (FII), FV, FVII, FVIII, FIX, FX, FXI and FXII were measured with Sekisui Medical Company’s Coapresta3000. α2 Plasmin inhibitor (α2PI, synthetic substrate assay), antithrombin (AT, synthetic substrate assay), thrombin-antithrombin complex (TAT, chemiluminescent enzyme immunoassay) and FXIII activity (synthetic substrate assay) were measured using the STACIA automated analyzer (LSI Medience Corporation, Tokyo, Japan).

The scientists reported that bleeding volume during surgery was 2,269 (174–10,607) mL. Number of transfusion units during surgery were packed red blood cells 12 (0–30) units, fresh frozen plasma 12 (0–44) units, platelets 20 (0–60) units and intraoperative autologous blood collection 669 (0–4,439) mL. Post-surgery activities of coagulation factors II (FII), FV, FVII, FVIII, FIX, FX, FXI and FXII were decreased. Values of fibrinogen, antithrombin, α2 plasmin inhibitor (α2PI) and FXIII were also decreased. Values of thrombin-antithrombin complex (TAT) were increased. Values of FII, FIX, FXI and α2PI before surgery were negatively correlated with bleeding volume. Level of FIX after surgery was negatively correlated with bleeding volume and level of TAT after surgery was positively correlated with bleeding volume.

The authors concluded that FII, FIX, FXI, FXIII and α2PI are associated with postoperative bleeding volume. Diluted coagulopathy, decrease in stabilized fibrin due to decrease in FXIII and hyperfibrinolysis due to decrease in α2PI may contribute to hemostatic defect. Thrombin burst due to operative stress as represented by increase in TAT values may also contribute to hemostatic defect. The study was published on October 9, 2021 in the Thrombosis Journal.

Related Links:
Asahikawa Medical University Hospital
Sekisui Medical Company
LSI Medience Corporation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more